KDM1 Histone Lysine Demethylases as Targets for Treatments of Oncological and Neurodegenerative Disease

References

• Shi Y , LanF , MatsonCet al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 . Cell119 ( 7 ), 941 – 953 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Lee MG , WynderC , SchmidtDM , McCaffertyDG , ShiekhattarR . Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications . Chem. Biol.13 ( 6 ), 563 – 567 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Schmidt DM , McCaffertyDG . Trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1 . Biochemistry46 ( 14 ), 4408 – 4416 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Zhang Q , QiS , XuMet al. Structure-function analysis reveals a novel mechanism for regulation of histone demethylase LSD2/AOF1/KDM1b . Cell Res.23 ( 2 ), 225 – 241 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Forneris F , BindaC , VanoniMA , BattaglioliE , MatteviA . Human histone demethylase LSD1 reads the histone code . J. Biol. Chem.280 ( 50 ), 41360 – 41365 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Tong JK , HassigCA , SchnitzlerGR , KingstonRE , SchreiberSL . Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex . Nature395 , 917 – 921 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Hakimi MA , BocharDA , ChenowethJet al. A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes . Proc. Natl Acad. Sci. USA99 , 7420 – 7425 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Hakimi MA , DongY , LaneWS , SpeicherDW , ShiekhattarR . A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes . J. Biol. Chem.278 , 7234 – 7239 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Humphrey GW , WangY , RussanovaVRet al. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/Kiaa0071 and Mta-L1 . J. Biol. Chem.276 , 6817 – 6824 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Shi YJ , SawadaJ-I , SuiGCet al. Coordinated histone modifications mediated by a CtBP co-repressor complex . Nature422 , 735 – 738 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Lee MG , WynderC , CoochN , ShiekhattarR . An essential role for RCOR1 in nucleosomal histone 3 lysine 4 demethylation . Nature437 ( 7057 ), 432 – 435 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Shi YJ , MatsonC , LanF , IwaseS , BabaT , ShiY . Regulation of LSD1 histone demethylase activity by its associated factors . Mol. Cell19 ( 6 ), 857 – 864 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Yang M , GockeCB , LuoXet al. Structural basis for RCOR1-dependent demethylation of nucleosomes by the human LSD1 histone demethylase . Mol. Cell23 ( 3 ), 377 – 387 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Whyte WA , BilodeauS , OrlandoDAet al. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation . Nature482 ( 7384 ), 221 – 225 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yokoyama A , TakezawaS , SchüleR , KitagawaH , KatoS . Transrepressive function of TLX requires the histone demethylase LSD1 . Mol. Cell Biol.28 ( 12 ), 3995 – 4003 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Banck MS , LiS , NishioH , WangC , BeutlerAS , WalshMJ . The ZNF217 oncogene is a candidate organizer of repressive histone modifiers . Epigenetics4 ( 2 ), 100 – 106 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gocke CB , YuH . ZNF198 stabilizes the LSD1-CoREST-HDAC1 complex on chromatin through its MYM-type zinc fingers . PLoS ONE3 ( 9 ), e3255 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Huang J , SenguptaR , EspejoABet al. p53 is regulated by the lysine demethylase LSD1 . Nature449 ( 7158 ), 105 – 108 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Hu X , LiX , ValverdeKet al. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis . Proc. Natl Acad. Sci. USA106 ( 25 ), 10141 – 10146 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lin Y , WuY , LiJet al. The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1 . EMBO J.29 ( 11 ), 1803 – 1816 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Saleque S , KimJ , RookeHM , OrkinSH . Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1 . Mol. Cell7 ( 4 ), 562 – 72 ( 2007 ).
   Google Scholar
• Metzger E , WissmannM , YinNet al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription . Nature437 ( 7057 ), 436 – 439 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Culhane JC , WangD , YenPM , ColePA . Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors . J. Am. Chem. Soc.132 ( 9 ), 3164 – 3176 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wissmann M , YinN , MüllerJMet al. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression . Nat. Cell Biol.9 ( 3 ), 347 – 353 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Liang Y , VogelJL , NarayananA , PengH , KristieTM . Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency . Nat. Med. ( 11 ), 1312 – 1317 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Liang Y , QuenelleD , VogelJL , MascaroC , OrtegaA , KristieTM . A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency . MBio.4 ( 1 ), e00558 – 12 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Musri MM , CarmonaMC , HanzuFA , KalimanP , GomisR , PárrizasM . Histone demethylase LSD1 regulates adipogenesis . J. Biol. Chem.285 ( 39 ), 30034 – 30041 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wang J , ScullyK , ZhuXet al. Opposing LSD1 complexes function in developmental gene activation and repression programmes . Nature446 ( 7138 ), 882 – 887 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Ciccone DN , SuH , HeviSet al. KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints . Nature461 , 415 – 418 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Katz TA , VasilatosSN , HarringtonE , OesterreichS , DavidsonNE , HuangY . Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells . Breast Cancer Res. Treat.146 ( 1 ), 99 – 108 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Fang R , BarberaAJ , XuYet al. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation . Mol. Cell39 ( 2 ), 222 – 233 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Karytinos A , FornerisF , ProfumoAet al. A novel mammalian flavin-dependent histone demethylase . J. Biol. Chem.284 ( 26 ), 17775 – 17782 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Chen F , YangH , DongZet al. Structural insight into substrate recognition by histone demethylase LSD2/KDM1b . Cell Res.23 ( 2 ), 306 – 309 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fang R , ChenF , DongZet al. LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation . Mol. Cell49 ( 3 ), 558 – 570 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yang Z , JiangJ , StewartDMet al. AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function . Cell Res.20 ( 3 ), 276 – 287 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• van Essen D , ZhuY , SaccaniS . A feed-forward circuit controlling inducible NF-αB target gene activation by promoter histone demethylation . Mol. Cell39 ( 5 ), 750 – 760 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kontaki H , TalianidisI . Lysine methylation regulates E2F1-induced cell death . Mol. Cell39 ( 1 ), 152 – 160 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wang J , HeviS , KurashJKet al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation . Nat. Genet.41 ( 1 ), 125 – 129 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Jin L , HaniganCL , WuYet al. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner . Biochem. J.449 ( 2 ), 459 – 468 ( 2013 ).
   PubMedGoogle Scholar
• Sprüssel A , SchulteJH , WeberSet al. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation . Leukemia26 ( 9 ), 2039 – 2051 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Nguyen AT , HeJ , TaranovaO , ZhangY . Essential role of DOT1L in maintaining normal adult hematopoiesis . Cell Res.21 ( 9 ), 1370 – 1373 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lund K , AdamsPD , CoplandM . EZH2 in normal and malignant hematopoiesis . Leukemia28 ( 1 ), 44 – 49 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wilting RH , YanoverE , HeidemanMRet al. Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis . EMBO J.29 ( 15 ), 2586 – 2597 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Rodriguez RM , Suarez-AlvarezB , SalvanésRet al. Role of BRD4 in hematopoietic differentiation of embryonic stem cells . Epigenetics9 ( 4 ), 566 – 578 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Saleque S , CameronS , OrkinSH . The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages . Genes Dev.16 ( 3 ), 301 – 306 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Laurent B , Randrianarison-HuetzV , KadriZ , RoméoPH , PorteuF , DuménilD . Gfi-1B promoter remains associated with active chromatin marks throughout erythroid differentiation of human primary progenitor cells . Stem Cells27 ( 9 ), 2153 – 2162 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lin XM , ZhongWT , WangCL , WangSQ . Expression of histone demethylase lysine specific demethylase 1 in acute leukemia and its clinical significance] . Zhongguo Shi Yan Xue Ye Xue Za Zhi.19 ( 6 ), 1348 – 1352 ( 2011 ).
   PubMedGoogle Scholar
• Harris WJ , HuangX , LynchJTet al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells . Cancer Cell21 ( 4 ), 473 – 487 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Binda C , ValenteS , RomanenghiMet al. Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2 . J. Am. Chem. Soc.132 ( 19 ), 6827 – 6833 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Schenk T , ChenWC , GöllnerSet al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-transretinoic acid differentiation pathway in acute myeloid leukemia . Nat. Med.18 ( 4 ), 605 – 611 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bash RO , HallS , TimmonsCFet al. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study . Blood86 ( 2 ), 666 – 676 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Li Y , DengC , HuXet al. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis . Oncogene31 ( 48 ), 5007 – 5018 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Weng AP , FerrandoAA , LeeWet al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia . Science306 , 269 – 271 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Yatim A , BenneC , SobhianBet al. NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function . Mol. Cell48 ( 3 ), 445 – 458 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mulligan P , YangF , Di StefanoLet al. A SIRT1-LSD1 corepressor complex regulates Notch target gene expression and development . Mol. Cell42 ( 5 ), 689 – 699 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Su ST , YingHY , ChiuYK , LinFR , ChenMY , LinKI . Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation . Mol. Cell Biol.29 ( 6 ), 1421 – 1431 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lim S , JanzerA , BeckerAet al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology . Carcinogenesis ( 3 ), 512 – 520 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Zhao ZK , YuHF , WangDRet al. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients . World J. Gastroenterol.18 ( 45 ), 6651 – 6656 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Serce N , GnatzyA , SteinerS , LorenzenH , KirfelJ , BuettnerR . Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast . BMC Clin. Pathol.12 – 13 ( 2012 ).
   PubMedGoogle Scholar
• Jie D , ZhongminZ , GuoqingLet al. Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer . Dig. Dis. Sci.58 ( 6 ), 1581 – 1589 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yu Y , WangB , ZhangKet al. High expression of lysine-specific demethylase 1 correlates with poor prognosis of patients with esophageal squamous cell carcinoma . Biochem. Biophys. Res. Commun.437 ( 2 ), 192 – 198 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ding J , ZhangZM , XiaYet al. LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer . Br. J. Cancer109 ( 4 ), 994 – 1003 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yuan C , LiZ , QiB , ZhangW , ChengJ , WangY . High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer . J. Oral Pathol. Med.44 ( 2 ), 159 – 165 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Derr RS , van HoeselAQ , BenardAet al. High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients . BMC Cancer14 , 604 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kahl P , GullottiL , HeukampLCet al. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence . Cancer Res.66 ( 23 ), 11341 – 11347 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Jerónimo C , BastianPJ , BjartellAet al. Epigenetics in prostate cancer: biologic and clinical relevance . Eur. Urol.60 ( 4 ), 753 – 766 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Cai C , HeHH , ChenSet al. Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1 . Cancer Cell20 ( 4 ), 457 – 471 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Metzger E , ImhofA , PatelDet al. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4 . Nature464 ( 7289 ), 792 – 796 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Willmann D , LimS , WetzelSet al. Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor . Int. J. Cancer131 ( 11 ), 2704 – 2709 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wu CY , HsiehCY , HuangKE , ChangC , KangHY . Cryptotanshinone down-regulates androgen receptor signaling by modulating lysine-specific demethylase 1 function . Int. J. Cancer131 ( 6 ), 1423 – 1434 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Althoff K , BeckersA , OderskyAet al. MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A . Int. J. Cancer133 ( 5 ), 1064 – 1073 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Schulte JH , LimS , SchrammAet al. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy . Cancer Res.69 ( 5 ), 2065 – 2071 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Pollock JA , LarreaMD , JasperJS , McDonnellDP , McCaffertyDG . Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERα-dependent and -independent manners . ACS Chem. Biol.7 ( 7 ), 1221 – 1231 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Cortez V , MannM , TekmalSet al. Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer . Breast Cancer Res.14 ( 4 ), R108 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Quinlan KG , VergerA , YaswenP , CrossleyM . Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad . Biochim. Biophys. Acta1775 ( 2 ), 333 – 340 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Wang Y , ZhangH , ChenYet al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer . Cell138 ( 4 ), 660 – 672 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hayami S , KellyJD , ChoHSet al. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers . Int. J. Cancer128 ( 3 ), 574 – 586 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lv T , YuanD , MiaoXet al. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer . PLoS ONE7 ( 4 ), e35065 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kruger R . Inhibition of LSD1 as a therapeutic strategy for the treatment of AML and SCLC . Presented at : 12th Annual Discovery on Target . Boston, MA, USA ( 10 October, 2014 ).
   Google Scholar
• Low WC , RujitanarojPO , LeeDKet al. Nanofibrous scaffold-mediated REST knockdown to enhance neuronal differentiation of stem cells . Biomaterials34 ( 14 ), 3581 – 3590 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sun G , AlzayadyK , StewartRet al. Histone demethylase LSD1 regulates neural stem cell proliferation . Mol. Cell Biol.30 ( 8 ), 1997 – 2005 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sun G , YeP , MuraiKet al. miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells . Nat. Commun.2 , 529 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Han X , GuiB , XiongCet al. Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural development . Mol. Cell55 ( 3 ), 482 – 494 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Fuentes P , CánovasJ , BerndtFA , NoctorSC , KukuljanM . RCOR1/LSD1 control the development of pyramidal cortical neurons . Cereb. Cortex22 ( 6 ), 1431 – 1441 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang YZ , ZhangQH , YeHet al. Distribution of lysine-specific demethylase 1 in the brain of rat and its response in transient global cerebral ischemia . Neurosci. Res.68 ( 1 ), 66 – 72 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Tan L , ZongC , XieXS . Rare event of histone demethylation can initiate singular gene expression of olfactory receptors . Proc. Natl Acad. Sci. USA110 ( 52 ), 21148 – 21152 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lyons DB , AllenWE , GohT , TsaiL , BarneaG , LomvardasS . An epigenetic trap stabilizes singular olfactory receptor expression . Cell154 ( 2 ), 325 – 336 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zibetti C , AdamoA , BindaCet al. Alternative splicing of the histone demethylase LSD1/KDM1 contributes to the modulation of neurite morphogenesis in the mammalian nervous system . J. Neurosci.30 ( 7 ), 2521 – 2532 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Toffolo E , RusconiF , PaganiniLet al. Phosphorylation of neuronal lysine-specific demethylase 1 LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2 . J. Neurochem.128 ( 5 ), 603 – 616 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Rusconi F , PaganiniL , BraidaDet al. LSD1 neurospecific alternative splicing controls neuronal excitability in mouse models of epilepsy . Cereb. CortexPMID: 24735673 ( 2014 ) ( Epub ahead of print ).
   Google Scholar
• Shimojo M . Huntingtin regulates RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) nuclear trafficking indirectly through a complex with REST/NRSF-interacting LIM domain protein (RILP) and dynactin p150 Glued . J. Biol. Chem.283 ( 50 ), 34880 – 34886 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Zuccato C , BelyaevN , ConfortiPet al. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington’s disease . J. Neurosci.27 ( 26 ), 6972 – 6983 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Soldati C , BithellA , JohnstonC , WongKY , StantonLW , BuckleyNJ . Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington’s disease . J. Neurochem.124 ( 3 ), 418 – 430 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Van Raamsdonk JM , MurphyZ , SlowEJ , LeavittBR , HaydenMR . Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease . Hum. Mol. Genet.14 ( 24 ), 3823 – 3835 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Kegel KB , MeloniAR , YiYet al. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription . J. Biol. Chem.277 ( 9 ), 7466 – 7476 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Soldati C , BithellA , ConfortiP , CattaneoE , BuckleyNJ . Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington’s disease . J. Neurochem.116 ( 3 ), 415 – 425 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Charbord J , PoydenotP , BonnefondCet al. High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes . Stem Cells31 ( 9 ), 1816 – 1828 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hockly E , RichonVM , WoodmanBet al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington’s disease . Proc. Natl Acad. Sci. USA100 ( 4 ), 2041 – 2046 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Thomas EA , CoppolaG , DesplatsPAet al. The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington’s disease transgenic mice . Proc. Natl Acad. Sci. USA105 ( 40 ), 15564 – 15569 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Conforti P , ZuccatoC , GaudenziGet al. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington’s disease models . J. Neurochem.127 ( 1 ), 22 – 35 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Maes T . LSD1 inhibition: a new therapeutic approach in neurodegenerative disease . Presented at : Alzheimer’s Drug Discovery Foundation Presymposium to the 3rd Clinical Trials on Alzheimer’s Disease . Toulouse, France , 3 November, 2010 .
   Google Scholar
• Abuhatzira L , MakedonskiK , KaufmanY , RazinA , ShemerR . MeCP2 deficiency in the brain decreases BDNF levels by REST/RCOR1-mediated repression and increases TRKB production . Epigenetics2 ( 4 ), 214 – 222 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Cukier HN , PerezAM , CollinsAL , ZhouZ , ZoghbiHY , BotasJ . Genetic modifiers of MeCP2 function in Drosophila . PLoS Genet.4 ( 9 ), e1000179 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Ripke S , SandersAR , KendlerKSet al. Genome-wide association study identifies five new schizophrenia loci . Nat. Genet.43 ( 10 ), 969 – 976 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Potkin SG , MacciardiF , GuffantiGet al. Identifying gene regulatory networks in schizophrenia . Neuroimage53 , 839 – 847 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kim AH , ParkerEK , WilliamsonV , McMichaelGO , FanousAH , VladimirovVI . Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137 . Schizophr. Res.141 ( 1 ), 60 – 64 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wright C , TurnerJA , CalhounVD , Perrone-BizzozeroN . Potential Impact of miR-137 and Its Targets in Schizophrenia . Front. Genet.4 , 58 ( 2013 ).
   PubMedGoogle Scholar
• Guella I , SequeiraA , RollinsBet al. Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex . J. Psychiatr. Res.47 ( 9 ), 1215 – 1221 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Neelamegam R , RicqEL , MalvaezMet al. Brain-penetrant LSD1 inhibitors can block memory consolidation . ACS Chem. Neurosci.3 ( 2 ), 120 – 128 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Gupta-Agarwal S , JaromeTJ , FernandezJ , LubinFD . NMDA receptor- and ERK-dependent histone methylation changes in the lateral amygdala bidirectionally regulate fear memory formation . Learn. Mem.21 ( 7 ), 351 – 62 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Maes T . LSD1/MAOB inhibitors as disease modifying drugs for Alzheimer’s disease . Presented at : 14th International Conference on Alzheimer’s Drug Discovery Conference Program . NJ, USA , 9–10 September 2013 .
   Google Scholar
• Maes T . Development of histone demethylase inhibitors for oncological and neurodegenerative disease . Presented at : 12th Annual Discovery on Target . Boston, MA, USA , 8–10 October 2014 .
   Google Scholar
• Maes T . Prospects of LSD1 inhibitors for the treatment of cancer and neurodegenerative disease . Presented at : 3rd Epigenetics in Drug Discovery Meeting . Boston, MA, USA , 8–10 May 2013 .
   Google Scholar
• Buesa C . ORY-1001, the first specific LSD1 inhibitor in acute myeloid leukemia therapy . Presented at : Epicongress . Boston, MA, USA , 22–24 July 2014 .
   Google Scholar
• Kruger RG , MohammadH , SmithemanKet al. Inhibition of LSD1 as a therapeutic strategy for the treatment of acute myeloid leukemia . Presented at : 5th ASH Annual Meeting and Exposition . New Orleans, LA, USA , 7–10 December 2013 .
   Google Scholar
• Sankar S , TheisenER , BearssJet al. Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth . Clin. Cancer Res.20 ( 17 ), 4584 – 4597 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Fiskus W , SharmaS , ShahBet al. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells . Leukemia14 , 752 ( 2014 ).
   Google Scholar
• Theisen ER , GajiwalaS , BearssJ , SornaV , SharmaS , Janat-AmsburyM . Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma . BMC Cancer14 , 752 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dahnak D . From chemistry to the clinic: pathways for drug discovery and development, part 2: targeting epigenetics: an epicenter of oncology drug discovery . AACR Annual Meeting . Washington, DC, USA , 6–10 April 2013 .
   Google Scholar
• Jo S , YarishkinO , HwangYJet al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer’s disease . Nat. Med.20 ( 8 ), 886 – 896 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Buesa C . Development of epigenetic modulator, ORY-2001, for neurodegenerative disease . Presented at : 15th International Conference on Alzheimer’s Drug Discovery . Jersey City, NJ, USA , 8–9 September 2014 .
   Google Scholar